{"slug":"selank-diabetic-neuropathy","verification":{"valid":true,"entries":2,"head":"916cf011d28bba33be4f74fe704c5b039846dfe152d79cef4741074e907f845c"},"energy":{"passes":2,"tokens_in":14264,"tokens_out":2798,"tokens_total":17062,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"916cf011d28bba33be4f74fe704c5b039846dfe152d79cef4741074e907f845c"},"provenance":[{"ts":"2026-06-30T00:46:04.648Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Selank for Diabetic Neuropathy\nSlug: selank-diabetic-neuropathy\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Diabetic neuropathy\",\"condition_key\":\"diabetic-neuropathy\",\"primary_peptide\":\"selank\",\"peptides_in_scope\":[{\"id\":\"selank\",\"name\":\"Selank\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Diabetic neuropathy\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"selank\",\"name\":\"Selank\",\"section_title\":\"Why Selank might help you\",\"layer\":\"anxiety / neurochemistry\",\"steps\":[\"You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\",\"**What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\",\"**What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\",\"**Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\\n2. **What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\\n3. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\\n4. **Therefore for you:** If that layer is part of your problem,","response":"```json\n{\n  \"slug\": \"selank-diabetic-neuropathy\",\n  \"title\": \"Selank for Diabetic Neuropathy: Evidence-Graded Review\",\n  \"body\": \"## What's breaking down if you have Diabetic neuropathy\\n\\nDiabetic neuropathy involves progressive nerve fiber damage driven by sustained high blood glucose. Oxidative stress, advanced glycation end-products, and microvascular ischemia impair axonal transport and myelin integrity. This leads to sensory loss, neuropathic pain, and autonomic dysfunction. Chronic hyperglycemia accelerates degeneration while impairing natural repair signals such as BDNF and NGF. Stress chemistry can amplify symptom perception through heightened central sensitization. Repair pathways that restore nerve conduction and reduce neuroinflammation are therefore relevant when degeneration outruns endogenous recovery.\\n\\n## Why Selank might help you\\n\\n1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\\n2. **What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\\n3. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\\n4. **Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\\n\\nIf chronic stress chemistry forms part of your diabetic neuropathy presentation, Selank's studied effects on GABA-related gene expression and anxiolytic signaling may support a neurochemical environment more conducive to nerve repair processes. Preclinical data show changes in neurotransmission genes after Selank administration in rat frontal cortex (mechanistic). This differs from symptom suppression because it engages pathways potentially linked to reduced allostatic load on already stressed nerves.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers liste","tokens_in":14264,"tokens_out":2798,"cost":0,"prev":"genesis","hash":"c1df7c1a9218f1803a93b9fa339428a818ed8f36bff52dec2057742f36f29d60"},{"ts":"2026-07-17T02:41:36.389Z","model":"owner","action":"voxel_divide","prompt":"","input":"selank-diabetic-neuropathy","response":"21 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"c1df7c1a9218f1803a93b9fa339428a818ed8f36bff52dec2057742f36f29d60","hash":"916cf011d28bba33be4f74fe704c5b039846dfe152d79cef4741074e907f845c"}]}